Ramelteon: A melatonin receptor agonist for the treatment of insomnia

Devi, Vasudha and Shankar, PK (2008) Ramelteon: A melatonin receptor agonist for the treatment of insomnia. Journal of Postgraduate Medicine, 54 (1). pp. 45-48. ISSN 0022-3859

[img] PDF
ramelteon_Vasudha-JPGM.pdf - Published Version
Restricted to Registered users only

Download (81kB) | Request a copy


Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since it lacks the potential for abuse and does not interact with neurotransmitter receptors most associated with these phenomena. Although the effects of ramelteon use >5 weeks are unknown, the available data confirms its safety and efficacy for short-term use. Clinical use and future research should uncover more information about ramelteon's properties.

Item Type: Article
Uncontrolled Keywords: Humans, melatonin, ramelteon, receptors
Subjects: Medicine > MMMC Manipal > Pharmacology
Depositing User: KMC Manipal
Date Deposited: 18 Sep 2012 10:12
Last Modified: 18 Sep 2012 10:12
URI: http://eprints.manipal.edu/id/eprint/77219

Actions (login required)

View Item View Item